The Comparison of Wet Suction and Dry Suction Technique in EUS-FNA for the Outcomes in Pancreatic Solid Lesions
1 other identifier
interventional
50
1 country
1
Brief Summary
The objective of this randomized controlled trial is to evaluate whether wet suction technique (WST), compared with dry suction technique (DST), shall present a better outcome with regard to the diagnostic yield and specimen quality of patients with solid lesions in the pancreatics.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 3, 2019
CompletedFirst Submitted
Initial submission to the registry
January 15, 2019
CompletedFirst Posted
Study publicly available on registry
January 30, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
March 31, 2020
CompletedJune 16, 2021
June 1, 2021
9 months
January 15, 2019
June 14, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The primary outcome is defined as the overall diagnosis yield of solid lesions by EUS-FNA with each aspiration technique.
The primary outcome is defined as the overall diagnosis yield of solid lesions by EUS-FNA with each aspiration technique.
20 weeks
Secondary Outcomes (4)
The second outcome is defined as the diagnose yield of first pass of solid lesions by EUS-FNA with each aspiration technique.
20 weeks
The third outcome is the diagnose yield in benign solid lesions by EUS-FNA with each aspiration technique.
20 weeks
The forth outcome is the diagnose yield in malignant solid lesions by EUS-FNA with each aspiration technique.
20 weeks
The fifth outcome is the diagnose yield in solid lesions in different parts of the pancreas by EUS-FNA with each aspiration technique.
20 weeks
Study Arms (2)
dry group
EXPERIMENTALThe sequence of the technique of the puncture is dry-wet-dry-wet.
wet group
EXPERIMENTALThe sequence of the technique of the puncture is wet-dry-wet-dry.
Interventions
For the wet suction technique, after removing the stylet, the needle was flushed with 2 mL of saline solution to replace the column of air with saline solution. A 10-mL suction syringe, loaded to 5ml negative pressure, was attached in a "locked" position to the needle after flushing the needle with saline solution. The needle is moved back and forth 20-30 times by applying negative pressure suction within the lesion. Afterwards, the needle is withdrawn from the lesion.
For the dry suction technique, after locating by EUS, the stylet was removed from the needle before performing FNA. A 10-mL syringe, loaded to 5ml negative pressure, was attached in a "locked" position to the needle. Suction was applied after the lesion was punctured. The needle is moved back and forth 20-30 times by applying negative pressure suction within the lesion. Afterwards, the needle is withdrawn from the lesion.
Eligibility Criteria
You may qualify if:
- Age \> 18 years, \< 80 years
- female or male
- Patients are required to undergo EUS-FNA after undergoing imaging examination (MRI, CT, or ultrasonography) which identify that the pancreatic lesions are existing and solid.
- Agree to attend this study and signed informed consent letter
You may not qualify if:
- bad physical condition, including hemoglobin ≤ 8.0 g/dl, severe cardiorespiratory dysfunction, and so on
- Coagulopathy (platelet count \< 50,000/mm3, international normalized ratio \> 1.5) or having taken oral anticoagulation agents such as aspirin or warfarin in the previous week
- Be rejected by anesthesia
- Acute pancreatitis in the previous 2 weeks
- Pregnant or lactation period
- Psychiatric disease, drug addiction, or other reason for unreliable follow-up or questionnaires
- Don't agree to attend this study and absence of informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The third Xiangya Hospital of central south University
Changsha, Hunan, 410003, China
Study Officials
- PRINCIPAL INVESTIGATOR
Li Tian, MD
The Third Xiangya Hospital of Central South University
- PRINCIPAL INVESTIGATOR
Ting Tong, MD
The Third Xiangya Hospital of Central South University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- DIAGNOSTIC
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 15, 2019
First Posted
January 30, 2019
Study Start
January 3, 2019
Primary Completion
September 30, 2019
Study Completion
March 31, 2020
Last Updated
June 16, 2021
Record last verified: 2021-06
Data Sharing
- IPD Sharing
- Will not share